Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 12 studies | 38% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 12882.82 | 2638 / 2642 | 94% | 29.86 | 664 / 705 |
lung | 89% | 2037.09 | 512 / 578 | 72% | 7.55 | 831 / 1155 |
kidney | 84% | 2833.30 | 75 / 89 | 71% | 12.55 | 644 / 901 |
breast | 85% | 2516.59 | 388 / 459 | 63% | 6.31 | 709 / 1118 |
thymus | 45% | 811.48 | 297 / 653 | 74% | 6.76 | 447 / 605 |
adrenal gland | 31% | 472.45 | 81 / 258 | 80% | 22.07 | 185 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 98.58 | 29 / 29 |
spleen | 100% | 5511.49 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 37% | 1494.43 | 356 / 966 | 54% | 4.72 | 287 / 527 |
ovary | 8% | 117.61 | 14 / 180 | 80% | 11.86 | 345 / 430 |
stomach | 25% | 352.26 | 88 / 359 | 62% | 6.64 | 176 / 286 |
adipose | 83% | 2240.59 | 1001 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 13.93 | 36 / 45 |
uterus | 35% | 636.94 | 59 / 170 | 43% | 2.99 | 196 / 459 |
esophagus | 19% | 290.01 | 280 / 1445 | 57% | 5.20 | 105 / 183 |
skin | 5% | 75.22 | 97 / 1809 | 67% | 10.18 | 317 / 472 |
pancreas | 1% | 7.57 | 2 / 328 | 72% | 7.81 | 128 / 178 |
peripheral blood | 64% | 5884.27 | 596 / 929 | 0% | 0 | 0 / 0 |
bladder | 19% | 250.43 | 4 / 21 | 40% | 3.23 | 202 / 504 |
eye | 0% | 0 | 0 / 0 | 55% | 4.63 | 44 / 80 |
prostate | 10% | 120.92 | 24 / 245 | 27% | 1.73 | 136 / 502 |
liver | 1% | 14.62 | 2 / 226 | 25% | 1.61 | 101 / 406 |
blood vessel | 13% | 234.85 | 178 / 1335 | 0% | 0 | 0 / 0 |
heart | 12% | 167.16 | 100 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051489 | Biological process | regulation of filopodium assembly |
GO_0051896 | Biological process | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1902309 | Biological process | negative regulation of peptidyl-serine dephosphorylation |
GO_1903670 | Biological process | regulation of sprouting angiogenesis |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0061028 | Biological process | establishment of endothelial barrier |
GO_1903589 | Biological process | positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis |
GO_0035308 | Biological process | negative regulation of protein dephosphorylation |
GO_0035307 | Biological process | positive regulation of protein dephosphorylation |
GO_0035304 | Biological process | regulation of protein dephosphorylation |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016607 | Cellular component | nuclear speck |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0005634 | Cellular component | nucleus |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0017020 | Molecular function | myosin phosphatase regulator activity |
GO_0019888 | Molecular function | protein phosphatase regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP1R16B |
Protein name | Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (hTIMAP) |
Synonyms | ANKRD4 KIAA0823 |
Description | FUNCTION: Regulator of protein phosphatase 1 (PP1) that acts as a positive regulator of pulmonary endothelial cell (EC) barrier function . Involved in the regulation of the PI3K/AKT signaling pathway, angiogenesis and endothelial cell proliferation . Regulates angiogenesis and endothelial cell proliferation through the control of ECE1 dephosphorylation, trafficking and activity (By similarity). Protects the endothelial barrier from lipopolysaccharide (LPS)-induced vascular leakage (By similarity). Involved in the regulation of endothelial cell filopodia extension (By similarity). May be a downstream target for TGF-beta1 signaling cascade in endothelial cells . Involved in PKA-mediated moesin dephosphorylation which is important in EC barrier protection against thrombin stimulation . Promotes the interaction of PPP1CA with RPSA/LAMR1 and in turn facilitates the dephosphorylation of RPSA/LAMR1 . Involved in the dephosphorylation of EEF1A1 . . |
Accessions | ENST00000299824.6 [Q96T49-1] Q96T49 ENST00000373331.2 [Q96T49-2] |